1. Home
  2. BBAR vs NVAX Comparison

BBAR vs NVAX Comparison

Compare BBAR & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBAR
  • NVAX
  • Stock Information
  • Founded
  • BBAR 1886
  • NVAX 1987
  • Country
  • BBAR Argentina
  • NVAX United States
  • Employees
  • BBAR N/A
  • NVAX N/A
  • Industry
  • BBAR Commercial Banks
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BBAR Finance
  • NVAX Health Care
  • Exchange
  • BBAR Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • BBAR 3.4B
  • NVAX 1.3B
  • IPO Year
  • BBAR N/A
  • NVAX 1995
  • Fundamental
  • Price
  • BBAR $16.28
  • NVAX $7.12
  • Analyst Decision
  • BBAR Buy
  • NVAX Buy
  • Analyst Count
  • BBAR 1
  • NVAX 5
  • Target Price
  • BBAR $27.00
  • NVAX $16.60
  • AVG Volume (30 Days)
  • BBAR 645.6K
  • NVAX 5.1M
  • Earning Date
  • BBAR 08-20-2025
  • NVAX 08-07-2025
  • Dividend Yield
  • BBAR 6.12%
  • NVAX N/A
  • EPS Growth
  • BBAR 9.91
  • NVAX N/A
  • EPS
  • BBAR 0.57
  • NVAX 2.97
  • Revenue
  • BBAR $2,595,064,489.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • BBAR N/A
  • NVAX $56.85
  • Revenue Next Year
  • BBAR $35.30
  • NVAX N/A
  • P/E Ratio
  • BBAR $9.01
  • NVAX $2.37
  • Revenue Growth
  • BBAR N/A
  • NVAX 25.92
  • 52 Week Low
  • BBAR $7.05
  • NVAX $5.01
  • 52 Week High
  • BBAR $25.01
  • NVAX $17.81
  • Technical
  • Relative Strength Index (RSI)
  • BBAR 40.81
  • NVAX 57.25
  • Support Level
  • BBAR $15.35
  • NVAX $6.54
  • Resistance Level
  • BBAR $16.54
  • NVAX $6.90
  • Average True Range (ATR)
  • BBAR 0.68
  • NVAX 0.29
  • MACD
  • BBAR 0.03
  • NVAX 0.06
  • Stochastic Oscillator
  • BBAR 42.24
  • NVAX 92.52

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: